Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.

@article{Liao2008RadiofrequencyAA,
  title={Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.},
  author={G S Liao and C Y Yu and Ming L. Shih and D C Chan and Yingrui Cyril Liu and Jian Chun Yu and Tiffany W Chen and C B Hsieh},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2008},
  volume={34 1},
  pages={61-6}
}
PURPOSE To evaluate the usefulness of transcatheter arterial embolization (TAE) followed by radiofrequency ablation (RFA) as combined treatment for unresectable hepatocellular carcinoma (HCC). PATIENTS AND METHODS Thirty-six consecutive patients (cirrhosis, Child-Pugh class A or B) with solitary or oligonodular HCC were treated (41 lesions; mean size, 58.9 mm; range, 30-120 mm). RFA was performed after one TAE treatment. Local efficacy was evaluated with multiphasic computed tomography (CT… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Interventional therapies for hepatocellular carcinoma

Cancer imaging : the official publication of the International Cancer Imaging Society • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…